Genus (LON:GNS) Sets New 1-Year High – Still a Buy?

Genus plc (LON:GNS) hit a new 52-week high during trading on Tuesday . The stock traded as high as GBX 3,220 and last traded at GBX 3,216.18, with a volume of 14473 shares. The stock had previously closed at GBX 3,135.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the stock. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Genus from GBX 3,100 to GBX 3,300 and gave the company a “buy” rating in a research report on Friday, January 16th. Shore Capital Group reissued a “buy” rating and issued a GBX 3,000 price target on shares of Genus in a report on Friday, January 16th. Finally, Berenberg Bank restated a “buy” rating and set a GBX 3,350 price target on shares of Genus in a research report on Thursday, February 5th. Three research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company has an average rating of “Buy” and a consensus price target of GBX 3,216.67.

Genus Price Performance

The company has a debt-to-equity ratio of 53.12, a current ratio of 1.80 and a quick ratio of 1.08. The firm has a 50-day simple moving average of GBX 2,804.21 and a 200 day simple moving average of GBX 2,634.27. The firm has a market cap of £2.14 billion, a PE ratio of 111.29, a price-to-earnings-growth ratio of 2.87 and a beta of 0.37.

Genus Company Profile

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.